Today: 30 June 2026
Browse Category

Singapore Stocks 14 January 2026 - 24 January 2026

Yangzijiang Shipbuilding stock drops again despite STI record — what investors watch next week

Yangzijiang Shipbuilding stock drops again despite STI record — what investors watch next week

Singapore, Jan 24, 2026, 14:54 SGT — Market closed Yangzijiang Shipbuilding Ltd shares dropped 1.2% to S$3.34 on Friday, marking the biggest decline on Singapore’s Straits Times Index, which itself hit a record close. “Washington’s noise has been loud, but the market is learning how to filter it,” said Stephen Innes, managing partner at SPI Asset Management.
UOB share price ends higher at S$36.74 as buybacks continue — what to watch next

UOB share price ends higher at S$36.74 as buybacks continue — what to watch next

Singapore, Jan 17, 2026, 14:53 SGT — Market closed Shares of United Overseas Bank Limited closed Friday up 0.9% at S$36.74, mirroring gains across Singapore’s big three banks as the Straits Times Index ticked up 0.3% by the close. Interactive Brokers senior economist Jose Torres pointed to “bullish sentiment” returning on Wall Street following Taiwan Semiconductor Manufacturing’s earnings, which helped steady risk appetite heading into the weekend.
1 2 3 4 5 8

Stock Market Today

  • Talawar Therapeutics to List Nasdaq as It Raises $285M for Atopic Dermatitis Drug
    June 30, 2026, 8:18 AM EDT. Talawar Therapeutics will go public on Nasdaq as 'TLWR' after pulling in $225 million through a PIPE plus $60 million from SPAC JATT II Acquisition, raising $285 million in total. The New Jersey biotech is developing TALA-125, an IL-13/IL-18 bispecific antibody aimed at atopic dermatitis, and is going up against Sanofi and Regeneron's top-selling Dupixent. Talawar says this new approach could get past limits of current therapies by targeting two immune pathways. The company expects to start Phase IIb trials by early 2027, with data coming in late 2028. AD sales could hit $22.4 billion by 2033, even as the field still sees unmet need.
Go toTop